Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 26.95%
March 31, 2026 25.57%
December 31, 2025 27.40%
September 30, 2025 25.43%
June 30, 2025 25.34%
March 31, 2025 24.25%
December 31, 2024 25.00%
September 30, 2024 24.08%
June 30, 2024 24.47%
March 31, 2024 24.84%
December 31, 2023 27.06%
September 30, 2023 24.90%
June 30, 2023 24.81%
March 31, 2023 24.43%
December 31, 2022 26.98%
September 30, 2022 26.66%
June 30, 2022 28.30%
March 31, 2022 27.66%
December 31, 2021 28.38%
September 30, 2021 28.53%
June 30, 2021 29.72%
March 31, 2021 28.66%
December 31, 2020 31.23%
September 30, 2020 30.97%
June 30, 2020 31.51%
Date Value
March 31, 2020 31.44%
December 31, 2019 31.75%
September 30, 2019 30.46%
June 30, 2019 30.63%
March 31, 2019 30.62%
December 31, 2018 32.09%
September 30, 2018 31.23%
June 30, 2018 30.95%
March 31, 2018 30.25%
December 31, 2017 33.71%
September 30, 2017 32.85%
June 30, 2017 33.44%
March 31, 2017 35.00%
December 31, 2016 33.97%
September 30, 2016 32.00%
June 30, 2016 31.64%
March 31, 2016 31.33%
December 31, 2015 33.76%
September 30, 2015 32.66%
June 30, 2015 30.90%
March 31, 2015 30.08%
December 31, 2014 32.70%
September 30, 2014 31.37%
June 30, 2014 31.64%
March 31, 2014 30.38%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
DaVita, Inc. 27.98%
Rhön-Klinikum AG -4.65%
FamiCord AG 55.98%
Quest Diagnostics, Inc. 32.53%
Acadia Healthcare Co., Inc. 16.58%